| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020135690 |
| P356 | DOI | 10.1007/S00292-011-1475-6 |
| P932 | PMC publication ID | 4237608 |
| P698 | PubMed publication ID | 21845360 |
| P2093 | author name string | N Wentzensen | |
| P2860 | cites work | Special commentary: patient safety and the next generation of HPV DNA tests | Q37775801 |
| The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. | Q44527945 | ||
| Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
| Human papillomavirus and cervical cancer | Q54023273 | ||
| Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test | Q58174349 | ||
| Carcinogenicity of human papillomaviruses | Q58296516 | ||
| Heterogeneity in CIN3 diagnosis | Q81204249 | ||
| A study of the impact of adding HPV types to cervical cancer screening and triage tests | Q81290015 | ||
| Biomarkers in cervical cancer screening | Q22306444 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Using biomarkers as objective standards in the diagnosis of cervical biopsies | Q30431203 | ||
| High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study | Q30452935 | ||
| A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study | Q33580897 | ||
| HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review | Q33762996 | ||
| A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia | Q33793914 | ||
| Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia | Q33978458 | ||
| Human papillomavirus testing in the prevention of cervical cancer | Q34616083 | ||
| Molecular diagnosis of human papillomavirus (HPV) infections | Q36064303 | ||
| Chapter 2: The burden of HPV-related cancers | Q36584354 | ||
| Human papillomavirus genotype specificity of hybrid capture 2 | Q36845399 | ||
| HPV detection methods | Q36878750 | ||
| Papillomavirus life cycle organization and biomarker selection | Q36878764 | ||
| Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study | Q37137085 | ||
| Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States | Q37147012 | ||
| Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older | Q37461977 | ||
| High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease | Q37656990 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 461-466 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Pathologe | Q15749166 |
| P1476 | title | Molecular diagnosis of HPV infections | |
| P478 | volume | 32 |
| Q43527960 | Early detection of cervical cancer in Germany: evidence and implementation | cites work | P2860 |
Search more.